| Crystal Structures of Pyridine Sulfonamides and Sulfonic acids K Akiri, S Cherukuvada, S Rana, A Nangia Crystal Growth & Design 12 (9), 4567–4573, 2012 | 45 | 2012 |
| Determinants of the specificity of protease‐activated receptors 1 and 2 signaling by factor Xa and thrombin S Rana, L Yang, SM Hassanian, AR Rezaie Journal of Cellular Biochemistry 113 (3), 977-984, 2012 | 32 | 2012 |
| Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region S Rana, TJ Baranski Journal of biological chemistry 285 (41), 31472-31483, 2010 | 32 | 2010 |
| A small peptide stereochemically customized as a globular fold with a molecular cleft S Rana, B Kundu, S Durani Chemical Communications, 207-209, 2005 | 26 | 2005 |
| A mixed‐α, β miniprotein stereochemically reprogrammed to high‐binding affinity for acetylcholine S Rana, B Kundu, S Durani Biopolymers: Original Research on Biomolecules 87 (4), 231-243, 2007 | 24 | 2007 |
| A double catgrip mixed L and D mini protein only 20 residues long S Rana, B Kundu, S Durani Bioorganic & medicinal chemistry 15 (11), 3874-3882, 2007 | 22 | 2007 |
| Stereospecific peptide folds. A rationally designed molecular bracelet S Rana, B Kundu, S Durani Chemical Communications, 2462-2463, 2004 | 21 | 2004 |
| The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered hC5a A Sahoo, R Mishra, S Rana Scientific Reports 8 (2955), 1, 2018 | 20 | 2018 |
| Model Structures of Inactive and Peptide Agonist Bound C5aR: Insights into Agonist Binding, Selectivity and Activation S Rana, A Sahoo Biochemistry and Biophysics Reports 1, 85-96, 2015 | 18 | 2015 |
| A Rational Search for Discovering Potential Neutraligands of Human Complement fragment 5a (hC5a) R Mishra, S Rana Bioorganic and Medicinal Chemistry 27 (19), 115052, 2019 | 16 | 2019 |
| Resveratrol Binding to Human Complement fragment 5a (hC5a) may Modulate the C5aR Signaling Axes. R Mishra, A Das, S Rana Journal of Biomolecular Structure and Dynamics, 1-15, 2020 | 13 | 2020 |
| Computational design of proteins stereochemically optimized in size, stability, and folding speed S Joshi, S Rana, P Wangikar, S Durani Biopolymers: Original Research on Biomolecules 83 (2), 122-134, 2006 | 13 | 2006 |
| Interaction of Human C5a with the Major Peptide Fragments of C5aR1: Direct Evidence in Support of “Two-Site” Binding Paradigm A Das, LM Behera, S Rana ACS Omega 6 (35), 22876–22887, 2021 | 12 | 2021 |
| The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics M Ghosh, S Rana International Immunopharmacology 118, 110081, 2023 | 11 | 2023 |
| Binding of raloxifene to human complement fragment 5a (hC5a): a perspective on cytokine storm and COVID19 R Mishra, LM Behera, S Rana Journal of Biomolecular Structure and Dynamics 40 (3), 982-994, 2022 | 11 | 2022 |
| The Role of Human C5a as a Non-genomic Target in Corticosteroid Therapy for Management of severe COVID19 A Das, S Rana Computational Biology and Chemistry 92, 107482, 2021 | 11 | 2021 |
| Structural Complexes of Agonist, Inverse Agonist and Antagonist Bound C5a Receptor: Insights into Pharmacology and Signaling S Rana, A Sahoo, BK Majhi Molecular BioSystems 12 (5), 1586-99, 2016 | 11 | 2016 |
| Allosterism in human Complement Component 5a (hC5a): A Damper of C5a Receptor (C5aR) Signaling. S Rana, A Sahoo, BK Majhi Journal of Biomolecular Structure and Dynamics 34 (6), 1201-13, 2016 | 9 | 2016 |
| Deciphering the conformational landscape of few selected aromatic noncoded amino acids (NCAAs) for applications in rational design of peptide therapeutics LM Behera, M Ghosh, S Rana Amino Acids 54 (8), 1183-1202, 2022 | 7 | 2022 |
| Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2 A Das, M Ghosh, PK Gupta, S Rana Journal of Cellular Biochemistry 124 (2), 266-281, 2023 | 5 | 2023 |
Bijoy kundu, Ph.D. (Retired)Medicinal Chemistry Division, CSIR-CDRI, LucknowVerified email at cdri.res.in
